It’s now or never.
Indian pharma has watched from the sidelines as e-pharmacies like 1mg and Medlife have swooped in, tossed distribution channels out, and increasingly become the direct link between pharma companies and patients. They hold patient data and monetise for behaviour; which, in pharma terms, is a bit of a superpower.
It’s now or never because if Indian pharma can’t fix this, it loses its connection with the one thing that matters—the patient.
The only way out of this tricky situation for pharma companies is to beat e-pharmacies at their own game.